| GO ID | GO name | Interaction type | Reference |
|---|---|---|---|
| GO:0000086 | G2/m transition of mitotic cell cycle | Affects phenotype | PMID:28415704 |
| GO:0000737 | Dna catabolic process, endonucleolytic | Increases phenotype | PMID:28703385; PMID:37704839 |
| GO:0001503 | Ossification | Increases phenotype | PMID:25062436; PMID:31472278; PMID:32324263; PMID:34020675; PMID:38081572; PMID:38914176 |
| GO:0001552 | Ovarian follicle atresia | Increases phenotype | PMID:23470461 |
| GO:0001649 | Osteoblast differentiation | Increases phenotype | PMID:27387537; PMID:28921615; PMID:30312686; PMID:30731080; PMID:30738844; PMID:31887333; PMID:38914176 |
| GO:0001776 | Leukocyte homeostasis | Affects phenotype | PMID:37704839 |
| GO:0001836 | Release of cytochrome c from mitochondria | Increases phenotype | PMID:25845326 |
| GO:0002076 | Osteoblast development | Increases phenotype | PMID:27028516 |
| GO:0002260 | Lymphocyte homeostasis | Affects phenotype | PMID:37704839 |
| GO:0002536 | Respiratory burst involved in inflammatory response | Increases phenotype | PMID:23692848 |
| GO:0002693 | Positive regulation of cellular extravasation | Increases phenotype | PMID:27020608; PMID:39325335 |
| GO:0003016 | Respiratory system process | Affects phenotype | PMID:23379631 |
| GO:0003331 | Positive regulation of extracellular matrix constituent secretion | Increases phenotype | PMID:26492236 |
| GO:0003341 | Cilium movement | Increases phenotype | PMID:32374624 |
| GO:0003918 | Dna topoisomerase type ii (double strand cut, atp-hydrolyzing) activity | Increases phenotype | PMID:33760604 |
| GO:0003954 | Nadh dehydrogenase activity | Decreases phenotype | PMID:32407874 |
| GO:0003990 | Acetylcholinesterase activity | Decreases phenotype | PMID:27941167 |
| GO:0003993 | Acid phosphatase activity | Increases phenotype | PMID:19391111 |
| GO:0004021 | L-alanine:2-oxoglutarate aminotransferase activity | Increases phenotype | PMID:31739238 |
| GO:0004035 | Alkaline phosphatase activity | Increases phenotype | PMID:19391111; PMID:23108452; PMID:23619517; PMID:25062436; PMID:27387537; PMID:28105418; PMID:28921615; PMID:31739238; PMID:32473317; PMID:34020675; PMID:38914176 |
| GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity | Increases phenotype | PMID:16758767; PMID:19391111; PMID:23108452; PMID:31739238 |
| GO:0004096 | Catalase activity | Decreases phenotype | PMID:37704839; PMID:38284084 |
| GO:0004111 | Creatine kinase activity | Increases phenotype | PMID:27941167 |
| GO:0004345 | Glucose-6-phosphate dehydrogenase activity | Decreases phenotype | PMID:38284084 |
| GO:0004346 | Glucose-6-phosphatase activity | Increases phenotype | PMID:16758767; PMID:38284084 |
| GO:0004364 | Glutathione transferase activity | Affects phenotype | PMID:16758767; PMID:18548748; PMID:23470461; PMID:25178734; PMID:31610155; PMID:33388378 |
| GO:0004396 | Hexokinase activity | Increases phenotype | PMID:38284084 |
| GO:0004402 | Histone acetyltransferase activity | Increases phenotype | PMID:25178734 |
| GO:0004407 | Histone deacetylase activity | Decreases phenotype | PMID:25178734 |
| GO:0004457 | Lactate dehydrogenase activity | Increases phenotype | PMID:23108452; PMID:24463055; PMID:27941167; PMID:31022331 |
| GO:0004602 | Glutathione peroxidase activity | Increases phenotype | PMID:18548748; PMID:19391111; PMID:23470461; PMID:28285367; PMID:29572072; PMID:31022331; PMID:32407874; PMID:32632975; PMID:38284084 |
| GO:0004683 | Calmodulin-dependent protein kinase activity | Increases phenotype | PMID:34286406 |
| GO:0004705 | Jun kinase activity | Increases phenotype | PMID:24907532 |
| GO:0004707 | Map kinase activity | Increases phenotype | PMID:24907532 |
| GO:0004784 | Superoxide dismutase activity | Affects phenotype | PMID:16758767; PMID:17879260; PMID:19391111; PMID:22870923; PMID:23470461; PMID:25178734; PMID:25721553; PMID:29572072; PMID:29992683; PMID:31022331; PMID:32632975; PMID:33475796; PMID:33592258; PMID:35187746; PMID:37704839; PMID:38284084 |
| GO:0004791 | Thioredoxin-disulfide reductase activity | Affects phenotype | PMID:25178734 |
| GO:0005975 | Carbohydrate metabolic process | Affects phenotype | PMID:35066937 |
| GO:0006089 | Lactate metabolic process | Affects phenotype | PMID:33475796; PMID:38160894 |
| GO:0006090 | Pyruvate metabolic process | Affects phenotype | PMID:38160894 |
| GO:0006102 | Isocitrate metabolic process | Decreases phenotype | PMID:24295472 |
| GO:0006123 | Mitochondrial electron transport, cytochrome c to oxygen | Increases phenotype | PMID:34089800 |
| GO:0006304 | Dna modification | Increases phenotype | PMID:26381084 |
| GO:0006309 | Apoptotic dna fragmentation | Increases phenotype | PMID:29992683; PMID:9694399; PMID:9828209 |
| GO:0006401 | Rna catabolic process | Increases phenotype | PMID:30140404 |
| GO:0006641 | Triglyceride metabolic process | Affects phenotype | PMID:33007364 |
| GO:0006693 | Prostaglandin metabolic process | Affects phenotype | PMID:28285367 |
| GO:0006702 | Androgen biosynthetic process | Decreases phenotype | PMID:28729172 |
| GO:0006729 | Tetrahydrobiopterin biosynthetic process | Increases phenotype | PMID:11243424 |
| GO:0006735 | Nadh regeneration | Decreases phenotype | PMID:24126434 |
| GO:0006749 | Glutathione metabolic process | Increases phenotype | PMID:23194016; PMID:24126434; PMID:24295472; PMID:24488945; PMID:28285367; PMID:31005848; PMID:31739238; PMID:32407874; PMID:35187746 |
| GO:0006750 | Glutathione biosynthetic process | Affects phenotype | PMID:16758767; PMID:17265541; PMID:17879260; PMID:18548748; PMID:19391111; PMID:21284339; PMID:22870923; PMID:25178734; PMID:25845326; PMID:27718046; PMID:29572072; PMID:29992683; PMID:30266311; PMID:31022331 |
| GO:0006754 | Atp biosynthetic process | Decreases phenotype | PMID:29158198; PMID:32407874 |
| GO:0006776 | Vitamin a metabolic process | Affects phenotype | PMID:28285367 |
| GO:0006805 | Xenobiotic metabolic process | Affects phenotype | PMID:24283477 |
| GO:0006809 | Nitric oxide biosynthetic process | Increases phenotype | PMID:23463385 |
| GO:0006915 | Apoptotic process | Increases phenotype | PMID:10079838; PMID:10502298; PMID:12356783; PMID:12478620; PMID:12496265; PMID:12606818; PMID:12750841; PMID:14632209; PMID:14871405; PMID:15158148; PMID:16397052; PMID:17041759; PMID:17325128; PMID:18344201; PMID:18442981; PMID:19301245; PMID:20179380; PMID:20737478; PMID:23470461; PMID:23535401; PMID:24732427; PMID:24907532; PMID:30526067; PMID:31585129; PMID:32632975; PMID:37704839; PMID:38160894; PMID:7811993; PMID:9224736; PMID:9247148; PMID:9252655; PMID:9359698; PMID:9694399 |
| GO:0006954 | Inflammatory response | Increases phenotype | PMID:22728154 |
| GO:0006974 | Cellular response to dna damage stimulus | Increases phenotype | PMID:17582584; PMID:23027624; PMID:25817893; PMID:29736388; PMID:30140404; PMID:32632975; PMID:33760604 |
| GO:0006979 | Response to oxidative stress | Increases phenotype | PMID:12423650; PMID:12477524; PMID:12767684; PMID:12949374; PMID:15379780; PMID:17487265; PMID:18549673; PMID:20025841; PMID:20028703; PMID:20525221; PMID:21104935; PMID:21114986; PMID:22530035; PMID:31032366; PMID:7797090; PMID:8900400 |
| GO:0007049 | Cell cycle | Decreases phenotype | PMID:16397052 |
| GO:0007283 | Spermatogenesis | Decreases phenotype | PMID:25637669; PMID:29663635; PMID:29940330; PMID:30240002; PMID:30526067; PMID:33372294 |
| GO:0007286 | Spermatid development | Decreases phenotype | PMID:30140404 |
| GO:0007613 | Memory | Affects phenotype | PMID:35187746 |
| GO:0007625 | Grooming behavior | Affects phenotype | PMID:35187746 |
| GO:0008203 | Cholesterol metabolic process | Affects phenotype | PMID:22421054; PMID:33007364 |
| GO:0008217 | Regulation of blood pressure | Decreases phenotype | PMID:9880127 |
| GO:0008219 | Cell death | Affects phenotype | PMID:11880902; PMID:12566691; PMID:12953835; PMID:14649725; PMID:15388883; PMID:15577407; PMID:15725397; PMID:16715183; PMID:17265541; PMID:17325128; PMID:20433922; PMID:24139157; PMID:24743698; PMID:25178734; PMID:25845326; PMID:27324791; PMID:29992683; PMID:31708536; PMID:33248029 |
| GO:0008283 | Cell population proliferation | Affects phenotype | PMID:16342676; PMID:25800560; PMID:26270818; PMID:37704839; PMID:38160894 |
| GO:0008284 | Positive regulation of cell population proliferation | Affects phenotype | PMID:23859036; PMID:24488945; PMID:24675465; PMID:25555879; PMID:27381660 |
| GO:0008285 | Negative regulation of cell population proliferation | Increases phenotype | PMID:20028703; PMID:22678527; PMID:25809564; PMID:30399392; PMID:33388378 |
| GO:0008443 | Phosphofructokinase activity | Decreases phenotype | PMID:38284084 |
| GO:0008584 | Male gonad development | Decreases phenotype | PMID:28729172 |
| GO:0009060 | Aerobic respiration | Decreases phenotype | PMID:24295472 |
| GO:0009110 | Vitamin biosynthetic process | Affects phenotype | PMID:31163222 |
| GO:0010189 | Vitamin e biosynthetic process | Decreases phenotype | PMID:19391111; PMID:21284339 |
| GO:0010424 | Dna methylation on cytosine within a cg sequence | Affects phenotype | PMID:27901495 |
| GO:0010694 | Positive regulation of alkaline phosphatase activity | Increases phenotype | PMID:31935364 |
| GO:0010729 | Positive regulation of hydrogen peroxide biosynthetic process | Increases phenotype | PMID:24675465; PMID:27941167 |
| GO:0010906 | Regulation of glucose metabolic process | Affects phenotype | PMID:38185084 |
| GO:0010917 | Negative regulation of mitochondrial membrane potential | Increases phenotype | PMID:25809564 |
| GO:0010918 | Positive regulation of mitochondrial membrane potential | Affects phenotype | PMID:24126434; PMID:24295472; PMID:24675465; PMID:34089800 |
| GO:0010940 | Positive regulation of necrotic cell death | Increases phenotype | PMID:23820267; PMID:24126434 |
| GO:0010942 | Positive regulation of cell death | Increases phenotype | PMID:20028703; PMID:23042718; PMID:23804405; PMID:24126434; PMID:25305479; PMID:25446496; PMID:25786529; PMID:25977998; PMID:27510327; PMID:39914626 |
| GO:0010983 | Positive regulation of high-density lipoprotein particle clearance | Increases phenotype | PMID:38284084 |
| GO:0010989 | Negative regulation of low-density lipoprotein particle clearance | Increases phenotype | PMID:38284084 |
| GO:0015747 | Urate transport | Increases phenotype | PMID:19391111 |
| GO:0015840 | Urea transport | Increases phenotype | PMID:19391111 |
| GO:0015882 | L-ascorbic acid transmembrane transport | Affects phenotype | PMID:25809564; PMID:31647942 |
| GO:0016042 | Lipid catabolic process | Increases phenotype | PMID:16758767; PMID:17265541; PMID:17879260; PMID:18548748; PMID:19391111; PMID:21284339; PMID:22728154; PMID:23470461; PMID:23619517; PMID:24026541; PMID:24523661; PMID:25178734; PMID:25721553; PMID:28259689; PMID:28285367; PMID:28709945; PMID:29572072; PMID:30140404; PMID:30526067; PMID:30676168; PMID:31585129; PMID:31610155; PMID:31739238; PMID:32407874; PMID:32632975; PMID:33007364; PMID:33248029; PMID:33475796; PMID:33592258; PMID:35187746; PMID:8968052 |
| GO:0016049 | Cell growth | Decreases phenotype | PMID:17879260; PMID:23212659; PMID:25178734; PMID:28690196; PMID:29467594; PMID:29663635 |
| GO:0016174 | Nad(p)h oxidase h2o2-forming activity | Increases phenotype | PMID:28285367 |
| GO:0016209 | Antioxidant activity | Decreases phenotype | PMID:29297235 |
| GO:0016358 | Dendrite development | Decreases phenotype | PMID:31708536 |
| GO:0017121 | Plasma membrane phospholipid scrambling | Increases phenotype | PMID:26139164 |
| GO:0018158 | Protein oxidation | Increases phenotype | PMID:12818473; PMID:12919963; PMID:18548748; PMID:23238474; PMID:25178734; PMID:26381084; PMID:28285367; PMID:32407874; PMID:37704839 |
| GO:0019228 | Neuronal action potential | Increases phenotype | PMID:33713149 |
| GO:0019627 | Urea metabolic process | Affects phenotype | PMID:21284339 |
| GO:0019852 | L-ascorbic acid metabolic process | Increases phenotype | PMID:20020850; PMID:20100038; PMID:20583318; PMID:22627169; PMID:23716880; PMID:23716880; PMID:26286522; PMID:33724628; PMID:23857379; PMID:25062976; PMID:25367288; PMID:26089033; PMID:26120027; PMID:26210702; PMID:26286522; PMID:28077287; PMID:28285367; PMID:28364781; PMID:29758312; PMID:30088836; PMID:31476248; PMID:31476248; PMID:33759307; PMID:31584213; PMID:31710167; PMID:32001261; PMID:32302048; PMID:32662567; PMID:32752303; PMID:33003968; PMID:33063951; PMID:33347680; PMID:33347680; PMID:35243731; PMID:33724628; PMID:33736254; PMID:33759307; PMID:34506763; PMID:34517062; PMID:34560258; PMID:34791780; PMID:34816538; PMID:35103375; PMID:35189178; PMID:35243731; PMID:36868495; PMID:37920212 |
| GO:0019853 | L-ascorbic acid biosynthetic process | Decreases phenotype | PMID:19391111; PMID:21284339; PMID:23470461 |
| GO:0020027 | Hemoglobin metabolic process | Affects phenotype | PMID:37704839 |
| GO:0030036 | Actin cytoskeleton organization | Affects phenotype | PMID:25758670 |
| GO:0030182 | Neuron differentiation | Increases phenotype | PMID:33713149 |
| GO:0030194 | Positive regulation of blood coagulation | Increases phenotype | PMID:26139164 |
| GO:0030263 | Apoptotic chromosome condensation | Increases phenotype | PMID:31708536; PMID:35187746; PMID:37704839 |
| GO:0030282 | Bone mineralization | Affects phenotype | PMID:12496288; PMID:25062436; PMID:27028516; PMID:27387537; PMID:30731080; PMID:30738844 |
| GO:0030316 | Osteoclast differentiation | Increases phenotype | PMID:26319416 |
| GO:0030321 | Transepithelial chloride transport | Increases phenotype | PMID:17215323 |
| GO:0030595 | Leukocyte chemotaxis | Increases phenotype | PMID:11861947 |
| GO:0031175 | Neuron projection development | Decreases phenotype | PMID:30075218 |
| GO:0031324 | Negative regulation of cellular metabolic process | Decreases phenotype | PMID:36063024 |
| GO:0031987 | Locomotion involved in locomotory behavior | Affects phenotype | PMID:35187746 |
| GO:0032024 | Positive regulation of insulin secretion | Increases phenotype | PMID:38284084 |
| GO:0032125 | Micronucleus organization | Increases phenotype | PMID:16758767; PMID:29736388; PMID:32632975 |
| GO:0032332 | Positive regulation of chondrocyte differentiation | Increases phenotype | PMID:26526931 |
| GO:0032436 | Positive regulation of proteasomal ubiquitin-dependent protein catabolic process | Decreases phenotype | PMID:26598004 |
| GO:0032496 | Response to lipopolysaccharide | Increases phenotype | PMID:30606963 |
| GO:0032755 | Positive regulation of interleukin-6 production | Affects phenotype | PMID:24239723 |
| GO:0032757 | Positive regulation of interleukin-8 production | Increases phenotype | PMID:25551565 |
| GO:0032760 | Positive regulation of tumor necrosis factor production | Affects phenotype | PMID:24239723 |
| GO:0032769 | Negative regulation of monooxygenase activity | Increases phenotype | PMID:28726718 |
| GO:0032914 | Positive regulation of transforming growth factor beta1 production | Affects phenotype | PMID:24239723 |
| GO:0032930 | Positive regulation of superoxide anion generation | Increases phenotype | PMID:24126434; PMID:24675465 |
| GO:0032964 | Collagen biosynthetic process | Affects phenotype | PMID:27028516 |
| GO:0032967 | Positive regulation of collagen biosynthetic process | Increases phenotype | PMID:27381660; PMID:31935364 |
| GO:0033327 | Leydig cell differentiation | Decreases phenotype | PMID:30526067 |
| GO:0034101 | Erythrocyte homeostasis | Affects phenotype | PMID:37704839 |
| GO:0034418 | Urate biosynthetic process | Affects phenotype | PMID:21284339 |
| GO:0034440 | Lipid oxidation | Affects phenotype | PMID:12818473; PMID:21751221; PMID:23238474; PMID:24295472; PMID:25305479; PMID:25637669; PMID:31005848; PMID:32805337; PMID:33372294; PMID:33388378; PMID:34089294 |
| GO:0035092 | Sperm dna condensation | Increases phenotype | PMID:30140404 |
| GO:0035640 | Exploration behavior | Affects phenotype | PMID:35187746 |
| GO:0035794 | Positive regulation of mitochondrial membrane permeability | Increases phenotype | PMID:22226756; PMID:24295472; PMID:24675465 |
| GO:0035934 | Corticosterone secretion | Increases phenotype | PMID:37704839 |
| GO:0035936 | Testosterone secretion | Decreases phenotype | PMID:23470461; PMID:30140404 |
| GO:0035937 | Estrogen secretion | Decreases phenotype | PMID:23470461 |
| GO:0036146 | Cellular response to mycotoxin | Increases phenotype | PMID:23719927 |
| GO:0036211 | Protein modification process | Increases phenotype | PMID:8723729 |
| GO:0036394 | Amylase secretion | Increases phenotype | PMID:38284084 |
| GO:0042178 | Xenobiotic catabolic process | Decreases phenotype | PMID:19138980 |
| GO:0042391 | Regulation of membrane potential | Decreases phenotype | PMID:29297235 |
| GO:0042554 | Superoxide anion generation | Increases phenotype | PMID:18548748; PMID:28285367; PMID:33592258 |
| GO:0042593 | Glucose homeostasis | Affects phenotype | PMID:38284084 |
| GO:0042632 | Cholesterol homeostasis | Affects phenotype | PMID:23194016; PMID:27941167 |
| GO:0042701 | Progesterone secretion | Decreases phenotype | PMID:23470461 |
| GO:0042743 | Hydrogen peroxide metabolic process | Affects phenotype | PMID:32632975 |
| GO:0043065 | Positive regulation of apoptotic process | Increases phenotype | PMID:23172806; PMID:23194016; PMID:23675469; PMID:24126434; PMID:24675465; PMID:7828537 |
| GO:0043123 | Positive regulation of i-kappab kinase/nf-kappab signaling | Affects phenotype | PMID:24239723 |
| GO:0043480 | Pigment accumulation in tissues | Affects phenotype | PMID:35150043 |
| GO:0043966 | Histone h3 acetylation | Increases phenotype | PMID:25178734 |
| GO:0043967 | Histone h4 acetylation | Increases phenotype | PMID:25178734 |
| GO:0044237 | Cellular metabolic process | Decreases phenotype | PMID:20465405; PMID:28285367; PMID:31610155; PMID:32632975; PMID:33248029; PMID:35478211; PMID:38160894 |
| GO:0044319 | Wound healing, spreading of cells | Decreases phenotype | PMID:29992683; PMID:38160894 |
| GO:0045333 | Cellular respiration | Decreases phenotype | PMID:24732427 |
| GO:0045429 | Positive regulation of nitric oxide biosynthetic process | Increases phenotype | PMID:20028703; PMID:24295472 |
| GO:0045444 | Fat cell differentiation | Increases phenotype | PMID:25062436; PMID:28758259; PMID:32473317 |
| GO:0045454 | Cell redox homeostasis | Decreases phenotype | PMID:26004525; PMID:26732703; PMID:30821249; PMID:31005848; PMID:32151596; PMID:33388378 |
| GO:0045669 | Positive regulation of osteoblast differentiation | Increases phenotype | PMID:26424790; PMID:26492236; PMID:28189605; PMID:30382123; PMID:30639440; PMID:31150804; PMID:31935364; PMID:32156525 |
| GO:0045722 | Positive regulation of gluconeogenesis | Increases phenotype | PMID:38284084 |
| GO:0045907 | Positive regulation of vasoconstriction | Increases phenotype | PMID:26599707 |
| GO:0045912 | Negative regulation of carbohydrate metabolic process | Increases phenotype | PMID:38284084 |
| GO:0045930 | Negative regulation of mitotic cell cycle | Increases phenotype | PMID:25178734; PMID:29736388; PMID:29992683 |
| GO:0046034 | Atp metabolic process | Increases phenotype | PMID:24732427; PMID:28703385; PMID:38160894 |
| GO:0046209 | Nitric oxide metabolic process | Increases phenotype | PMID:30606963 |
| GO:0046330 | Positive regulation of jnk cascade | Increases phenotype | PMID:24488945 |
| GO:0046449 | Creatinine metabolic process | Affects phenotype | PMID:19391111; PMID:21284339 |
| GO:0046466 | Membrane lipid catabolic process | Increases phenotype | PMID:10580364; PMID:10690761; PMID:10741692; PMID:10741692; PMID:20524970; PMID:11551671; PMID:12197998; PMID:12531249; PMID:18758914; PMID:12755500; PMID:12763288; PMID:12767684; PMID:1544873; PMID:16187034; PMID:18549673; PMID:18758914; PMID:20025841; PMID:20028703; PMID:20524970; PMID:21452598; PMID:23194016; PMID:2353831; PMID:2366755; PMID:23692848; PMID:26921358; PMID:2706019; PMID:2769018; PMID:27941167; PMID:30240002; PMID:3587766; PMID:6619568; PMID:6650302; PMID:7248325; PMID:7495250; PMID:7616398; PMID:7732629; PMID:8900400; PMID:9139234; PMID:9303565; PMID:9764785; PMID:9765353; PMID:9806698 |
| GO:0046620 | Regulation of organ growth | Increases phenotype | PMID:1544873 |
| GO:0046902 | Regulation of mitochondrial membrane permeability | Affects phenotype | PMID:18022205 |
| GO:0048715 | Negative regulation of oligodendrocyte differentiation | Increases phenotype | PMID:35701726 |
| GO:0050665 | Hydrogen peroxide biosynthetic process | Increases phenotype | PMID:23470461 |
| GO:0050729 | Positive regulation of inflammatory response | Increases phenotype | PMID:23692848 |
| GO:0051092 | Positive regulation of nf-kappab transcription factor activity | Increases phenotype | PMID:17879260; PMID:23692848 |
| GO:0051348 | Negative regulation of transferase activity | Affects phenotype | PMID:33388378 |
| GO:0051458 | Corticotropin secretion | Increases phenotype | PMID:37704839 |
| GO:0051562 | Negative regulation of mitochondrial calcium ion concentration | Increases phenotype | PMID:24295472 |
| GO:0051726 | Regulation of cell cycle | Increases phenotype | PMID:23172806 |
| GO:0051881 | Regulation of mitochondrial membrane potential | Affects phenotype | PMID:24907532; PMID:32407874; PMID:33592258 |
| GO:0051882 | Mitochondrial depolarization | Increases phenotype | PMID:30266311; PMID:33248029 |
| GO:0051901 | Positive regulation of mitochondrial depolarization | Increases phenotype | PMID:22226756; PMID:22678527 |
| GO:0051924 | Regulation of calcium ion transport | Affects phenotype | PMID:25758670 |
| GO:0055074 | Calcium ion homeostasis | Affects phenotype | PMID:27718046 |
| GO:0055088 | Lipid homeostasis | Decreases phenotype | PMID:24295472 |
| GO:0060326 | Cell chemotaxis | Decreases phenotype | PMID:29992683; PMID:38160894 |
| GO:0060591 | Chondroblast differentiation | Increases phenotype | PMID:26492236 |
| GO:0060996 | Dendritic spine development | Increases phenotype | PMID:33872575 |
| GO:0061024 | Membrane organization | Decreases phenotype | PMID:26808022 |
| GO:0061370 | Testosterone biosynthetic process | Decreases phenotype | PMID:29663635; PMID:30526067; PMID:33372294 |
| GO:0061890 | Positive regulation of astrocyte activation | Increases phenotype | PMID:34286406 |
| GO:0070169 | Positive regulation of biomineral tissue development | Increases phenotype | PMID:26492236; PMID:28189605; PMID:30382123; PMID:31935364 |
| GO:0070254 | Mucus secretion | Increases phenotype | PMID:32374624 |
| GO:0070265 | Necrotic cell death | Increases phenotype | PMID:33372294 |
| GO:0070328 | Triglyceride homeostasis | Decreases phenotype | PMID:23194016; PMID:27941167; PMID:31005848; PMID:38284084 |
| GO:0070365 | Hepatocyte differentiation | Increases phenotype | PMID:23108452 |
| GO:0070368 | Positive regulation of hepatocyte differentiation | Increases phenotype | PMID:34480604 |
| GO:0070585 | Protein localization to mitochondrion | Decreases phenotype | PMID:25809564 |
| GO:0070661 | Leukocyte proliferation | Increases phenotype | PMID:37704839 |
| GO:0070994 | Detection of oxidative stress | Increases phenotype | PMID:31576639; PMID:34601066; PMID:35187746; PMID:37704839; PMID:38439645 |
| GO:0070995 | Nadph oxidation | Decreases phenotype | PMID:24295472 |
| GO:0070997 | Neuron death | Increases phenotype | PMID:35187746 |
| GO:0071493 | Cellular response to uv-b | Decreases phenotype | PMID:19138980; PMID:36063024 |
| GO:0071542 | Dopaminergic neuron differentiation | Decreases phenotype | PMID:25891525 |
| GO:0071902 | Positive regulation of protein serine/threonine kinase activity | Increases phenotype | PMID:34286406 |
| GO:0072593 | Reactive oxygen species metabolic process | Increases phenotype | PMID:15055539; PMID:18442981; PMID:22530035; PMID:24463055; PMID:24732427; PMID:25800560; PMID:28285367; PMID:28415704; PMID:32407874; PMID:33007364; PMID:33248029; PMID:33372294; PMID:33475796; PMID:33592258; PMID:35349355; PMID:35478211; PMID:37704839; PMID:38042493 |
| GO:0090026 | Positive regulation of monocyte chemotaxis | Increases phenotype | PMID:25551565 |
| GO:0090116 | C-5 methylation of cytosine | Decreases phenotype | PMID:33388378 |
| GO:0090200 | Positive regulation of release of cytochrome c from mitochondria | Increases phenotype | PMID:22678527 |
| GO:0090398 | Cellular senescence | Increases phenotype | PMID:36500241 |
| GO:0097045 | Phosphatidylserine exposure on blood platelet | Increases phenotype | PMID:31428780 |
| GO:0097214 | Positive regulation of lysosomal membrane permeability | Increases phenotype | PMID:22678527 |
| GO:0097722 | Sperm motility | Decreases phenotype | PMID:29158198; PMID:30140404; PMID:30526067 |
| GO:0098658 | Inorganic anion import across plasma membrane | Decreases phenotype | PMID:25977998 |
| GO:0098703 | Calcium ion import across plasma membrane | Increases phenotype | PMID:23820267 |
| GO:0098869 | Cellular oxidant detoxification | Increases phenotype | PMID:30512238; PMID:31433962; PMID:31545954; PMID:34655286 |
| GO:0140042 | Lipid droplet formation | Increases phenotype | PMID:28758259 |
| GO:1900015 | Regulation of cytokine production involved in inflammatory response | Affects phenotype | PMID:24239723 |
| GO:1900745 | Positive regulation of p38mapk cascade | Increases phenotype | PMID:24142891; PMID:24488945; PMID:29940330; PMID:31935364 |
| GO:1901224 | Positive regulation of nik/nf-kappab signaling | Increases phenotype | PMID:27381660 |
| GO:1901670 | Negative regulation of superoxide dismutase activity | Increases phenotype | PMID:20028703; PMID:23194016; PMID:27941167; PMID:33388378; PMID:34089294 |
| GO:1901671 | Positive regulation of superoxide dismutase activity | Affects phenotype | PMID:24295472; PMID:25305479; PMID:31005848 |
| GO:1901687 | Glutathione derivative biosynthetic process | Decreases phenotype | PMID:24295472 |
| GO:1901896 | Positive regulation of atpase-coupled calcium transmembrane transporter activity | Decreases phenotype | PMID:24295472 |
| GO:1902093 | Positive regulation of flagellated sperm motility | Decreases phenotype | PMID:25637669 |
| GO:1902107 | Positive regulation of leukocyte differentiation | Decreases phenotype | PMID:27020608 |
| GO:1902174 | Positive regulation of keratinocyte apoptotic process | Affects phenotype | PMID:19138980 |
| GO:1902512 | Positive regulation of apoptotic dna fragmentation | Increases phenotype | PMID:22678527; PMID:24295472; PMID:24488945; PMID:25809564 |
| GO:1902514 | Regulation of calcium ion transmembrane transport via high voltage-gated calcium channel | Affects phenotype | PMID:23820267 |
| GO:1902552 | Negative regulation of catalase activity | Increases phenotype | PMID:20028703; PMID:23194016; PMID:30738991 |
| GO:1902553 | Positive regulation of catalase activity | Increases phenotype | PMID:30240002 |
| GO:1902884 | Positive regulation of response to oxidative stress | Increases phenotype | PMID:27941167 |
| GO:1902958 | Positive regulation of mitochondrial electron transport, nadh to ubiquinone | Decreases phenotype | PMID:24295472 |
| GO:1903012 | Positive regulation of bone development | Increases phenotype | PMID:25932594 |
| GO:1903047 | Mitotic cell cycle process | Affects phenotype | PMID:28415704 |
| GO:1903220 | Positive regulation of malate dehydrogenase (decarboxylating) (nadp+) activity | Decreases phenotype | PMID:24295472 |
| GO:1903283 | Negative regulation of glutathione peroxidase activity | Increases phenotype | PMID:23194016; PMID:27941167; PMID:30240002; PMID:33388378; PMID:34089294 |
| GO:1903284 | Positive regulation of glutathione peroxidase activity | Affects phenotype | PMID:24295472; PMID:25305479; PMID:26545973 |
| GO:1903408 | Positive regulation of p-type sodium:potassium-exchanging transporter activity | Decreases phenotype | PMID:24295472 |
| GO:1903409 | Reactive oxygen species biosynthetic process | Affects phenotype | PMID:18548748; PMID:19301245; PMID:22728154; PMID:25178734; PMID:25845326; PMID:26270818; PMID:27345029; PMID:29158198; PMID:29297235; PMID:29663635; PMID:29992683; PMID:30266311; PMID:31276663; PMID:31585129; PMID:31610155; PMID:31610156; PMID:31647942 |
| GO:1903427 | Negative regulation of reactive oxygen species biosynthetic process | Affects phenotype | PMID:23284918 |
| GO:1903428 | Positive regulation of reactive oxygen species biosynthetic process | Affects phenotype | PMID:1764212; PMID:23172806; PMID:23692848; PMID:24026617; PMID:24142891; PMID:24295472; PMID:25305479; PMID:27381660; PMID:27510327; PMID:28703385; PMID:29940330; PMID:30399392; PMID:30597948; PMID:32028152; PMID:33388378; PMID:36063024 |
| GO:1903578 | Regulation of atp metabolic process | Increases phenotype | PMID:24126434 |
| GO:1903626 | Positive regulation of dna catabolic process | Increases phenotype | PMID:1764212 |
| GO:1903935 | Response to sodium arsenite | Decreases phenotype | PMID:20028703 |
| GO:1904028 | Positive regulation of collagen fibril organization | Increases phenotype | PMID:39325335 |
| GO:1904094 | Positive regulation of autophagic cell death | Increases phenotype | PMID:24675465 |
| GO:1904146 | Positive regulation of meiotic cell cycle process involved in oocyte maturation | Increases phenotype | PMID:26545973 |
| GO:1904231 | Positive regulation of succinate dehydrogenase activity | Decreases phenotype | PMID:24295472 |
| GO:1904445 | Negative regulation of establishment of sertoli cell barrier | Decreases phenotype | PMID:29940330 |
| GO:1904960 | Positive regulation of cytochrome-c oxidase activity | Decreases phenotype | PMID:24295472 |
| GO:1905665 | Positive regulation of calcium ion import across plasma membrane | Increases phenotype | PMID:34286406 |
| GO:1990414 | Replication-born double-strand break repair via sister chromatid exchange | Increases phenotype | PMID:22342611 |
| GO:2000083 | Negative regulation of l-ascorbic acid biosynthetic process | Increases phenotype | PMID:32805337 |
| GO:2000225 | Negative regulation of testosterone biosynthetic process | Increases phenotype | PMID:30240002 |
| GO:2000375 | Negative regulation of oxygen metabolic process | Increases phenotype | PMID:25809564 |
| GO:2000376 | Positive regulation of oxygen metabolic process | Increases phenotype | PMID:23675469 |
| GO:2000379 | Positive regulation of reactive oxygen species metabolic process | Increases phenotype | PMID:22678527; PMID:25305479 |
| GO:2000738 | Positive regulation of stem cell differentiation | Decreases phenotype | PMID:25786529 |
| GO:2000786 | Positive regulation of autophagosome assembly | Increases phenotype | PMID:24675465 |
| GO:2001057 | Reactive nitrogen species metabolic process | Affects phenotype | PMID:32407874 |
| GO:2001170 | Negative regulation of atp biosynthetic process | Increases phenotype | PMID:33147516 |
We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.